Skip to main content

Select Drug Profiles

Perspectives
Advancing Anticoagulation Safety: Focus on Factor Xa Reversal
Read More
Original Research
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making
Madison M. Wempe, BS, Mark D. Stewart, PhD, Daniel Glass, PhD, Laura Lasiter, PhD, Diana Merino Vega, PhD, Nisha Ramamurthy, Jeff Allen, PhD, Ellen V. Sigal, PhD
Madison M. Wempe, BS; Mark D. Stewart, PhD; Daniel Glass, PhD; Laura Lasiter, PhD; Diana Merino Vega, PhD; Nisha Ramamurthy; Jeff Allen, PhD; Ellen V. Sigal, PhD
Stakeholder Perspective
Navigating the Complex World of Diagnostic Tests and Their Role in Clinical Decision-Making
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Read More
Practice Management
Return to Business During a Pandemic: Market Collaboration and Health Benefit Trends
F. Randy Vogenberg, PhD, FASHP
F. Randy Vogenberg, PhD, RPh
Read More
Perspectives
Healthcare Disrupters
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Practice Management
Preparing for Healthcare After COVID-19: New Challenges Facing Payers
Wayne Kuznar
Wayne Kuznar
Read More
Original Research, Practice Management
Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition
Suela Sulo, PhD, MSc, David Lanctin, MPH, Josh Feldstein, BA, Bjoern Schwander, MA, RN, Jamie Partridge, PhD, MBA, Wendy Landow, MPH, York F. Zöllner, MSc
Suela Sulo, PhD, MSc; David Lanctin, MPH; Josh Feldstein, BA; Bjoern Schwander, MA, RN; Jamie Partridge, PhD, MBA; Wendy Landow, MPH; York F. Zöllner, MSc
Read More
FDA Approvals
Opdivo Approved for Advanced Esophageal Squamous-Cell Carcinoma
Read More
FDA Approvals, Lung Cancer, Oncology
FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation
Read More
FDA Approvals, Lung Cancer, Oncology
Opdivo plus Yervoy and Limited Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC, Regardless of PD-L1 Expression
Read More
FDA Approvals, Lung Cancer, Oncology
Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma
Read More
Page 34 of 244
Results 331 - 340 of 2434